Evolutionary medicine: from dwarf model systems to healthy centenarians?

Area of Science:

• Gerontology
• Metabolic research
• Molecular biology

Background:

• Caloric restriction (CR) is a dietary intervention known to extend lifespan across diverse species.
• In rodents, CR reduces plasma glucose and insulin-like growth factor I (IGF-1) levels.
• CR has been observed to postpone or attenuate age-related conditions such as cancer, immunosenescence, and inflammation without significant adverse effects.

Purpose of the Study:

• To explore the molecular mechanisms underlying the life-extending effects of caloric restriction.
• To investigate the role of glucose and IGF-1 signaling pathways in aging and age-related diseases.
• To identify potential therapeutic targets for preventing or delaying diseases associated with aging.

Main Methods:

• Review of existing literature on caloric restriction and aging in various model organisms, including yeast and rodents.
• Analysis of the impact of CR on key metabolic markers like plasma glucose and IGF-1.
• Examination of the effects of genetic mutations in glucose and IGF-1 signaling pathways on lifespan and physiological outcomes.

Main Results:

• Caloric restriction consistently extends longevity in multiple organisms.
• CR in rodents leads to decreased plasma glucose and IGF-1 levels.
• Mutations in glucose or IGF-1 signaling pathways also extend lifespan but can result in adverse effects like glycogen/fat accumulation and dwarfism.

Conclusions:

• The findings suggest that targeting glucose and IGF-1 signaling pathways holds promise for interventions against age-related diseases.
• Developing drugs that modulate these pathways could offer a strategy to postpone aging and associated pathologies with potentially fewer side effects than genetic mutations.
• This research supports the development of a new class of drugs aimed at promoting healthy aging and preventing age-related diseases.